Home > Insider Trading > Filing (0001104659-23-119188)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1429260	Fortress Biotech Inc.	FBIO	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
941841	Md A Lindsay Rosenwald	C/O Fortress Biotech, Inc. 1111 Kane Concourse Suite 301 Bay Harbor Islands FL 33154	President, Ceo & Chairman	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.001	Acquisiton	2023-11-14	1,567,515	$1.70	2,597,440	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrants to purchase Common Stock	Acquisiton	2023-11-14	1,567,515	$0.00	1,567,515	$1.70

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
1,567,515	2023-11-14	2028-11-14	No	4	P	Direct

Footnotes

Effective October 10, 2023, the Issuer effected a one-for-fifteen reverse stock split of its common stock (the "Reverse Split"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Split.
The shares of common stock and warrants to purchase common stock reflect on this Form 4 were purchased as units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock, at a price per unit of $1.70.